J. Guico Pabia - 29 Oct 2021 Form 4 Insider Report for Nabriva Therapeutics plc

Role
Chief Medical Officer
Signature
/s/ J. Christopher Naftzger, power of attorney
Issuer symbol
N/A
Transactions as of
29 Oct 2021
Net transactions value
$0
Form type
4
Filing time
01 Nov 2021, 18:10:22 UTC
Previous filing
07 Oct 2021
Next filing
01 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBRV Share Option Award $0 +100,000 $0.000000 100,000 29 Oct 2021 Ordinary Shares 100,000 $1.15 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on October 29, 2021.
F2 The option will vest over a four-year period. Twenty-five percent (25%) of the option will vest on the one (1)-year anniversary of the date of grant, and the remaining seventy-five percent (75%) of the option will vest on an annual pro-rata basis over the remaining vesting period.